Compare AU
Compare JZRO vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Janus Henderson Net Zero Transition Active ETF (JZRO) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
JZRO | DRUG | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 61 |
Median incremental investment | $0 | $920.50 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $2,012.38 |
Average age group | N/A | 26 - 35 |
Key Summary
JZRO | DRUG | |
|---|---|---|
Strategy | JZRO.AX was created on 2022-03-09 by Janus Henderson. The fund's investment portfolio concentrates primarily on theme equity. The Fund seeks to achieve a total return after fees that exceeds the total return of the Benchmark over rolling 5 year periods. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Nutrien Ltd (5.60 %) Pan American Silver Corp (4.76 %) Cameco Corp (4.45 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Materials (78.76 %) Utilities (11.16 %) Energy (10.84 %) | Other (75.92 %) Communication Services (33.53 %) Health Care (23.94 %) |
Top 3 countries | Canada (41.39 %) United States (27.57 %) Australia (7.16 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.85 % | 0.57 % |
Key Summary
JZRO | DRUG | |
|---|---|---|
Issuer | Janus Henderson | BetaShares |
Tracking index | S&P Global Natural Resources | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.85 % | 0.57 % |
Price | $25.77 | $8.42 |
Size | N/A | $195.730 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.99 % | 1.89 % |
Market | ASX | ASX |
First listed date | 29/03/2022 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
JZRO | DRUG | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 61 |
Median incremental investment | $0 | $920.50 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $2,012.38 |
Average age group | N/A | 26 - 35 |
Pros and Cons
JZRO | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
JZRO | DRUG |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |